In the version of this article that was originally published online, an older version of the data set categorizing proteins into target development levels was used to create Figure 1 than the version used to create Table 1, and data from Figure 1 were referred to at several points in the text of the article. Figure 1 and the associated text have been updated to match Table 1 in the online and print versions of the article. The authors apologize for any inconvenience that this error may have caused.
Additional information
The online version of the original article can be found at https://doi.org/10.1038/nrd.2018.14
Rights and permissions
About this article
Cite this article
Oprea, T., Bologa, C., Brunak, S. et al. Erratum: Unexplored therapeutic opportunities in the human genome. Nat Rev Drug Discov 17, 377 (2018). https://doi.org/10.1038/nrd.2018.52
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2018.52
This article is cited by
-
PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
Molecular Cancer (2023)
-
Knowledge graph analytics platform with LINCS and IDG for Parkinson's disease target illumination
BMC Bioinformatics (2022)
-
Machine learning prediction and tau-based screening identifies potential Alzheimer’s disease genes relevant to immunity
Communications Biology (2022)
-
The Deep Genome Project
Genome Biology (2020)
-
Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs
Nature Structural & Molecular Biology (2019)
